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Abstract
Despite the highest historical live birth success rates for couples undergoing in vitro fertilization (IVF), there has
been an epidemic of iatrogenic twin and higher order gestation conceived from this treatment. Continued
improvement in cryopreservation techniques have allowed preservation of supernumerary embryos for use in
future cycles, and refinements in culture systems and embryo selection have resulted in the transfer of fewer
embryos while maintaining favorable pregnancy rates. The voluntary transfer of a single high quality embryo,
elective single embryo transfer (eSET), has significantly reduced multiple gestation rates and maximized the rate
of singleton pregnancy without compromising overall success rates. Although eSET is the standard of care in
several developed countries, utilization in the United States has been slow. States with mandated IVF insurance
have seen decreases in preterm birth rates yielding down stream health care savings. Herein, the evolution and
future applications of this practice to reduce the risk of iatrogenic twins is reviewed.
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Background
Since its inception in 1978, in vitro fertilization (IVF)
has resulted in nearly 4 million births. Initially, IVF
utilized unstimulated, natural cycles with laparoscopic
oocyte retrievals and was fraught with inefficiencies and
low pregnancy rates. The subsequent use of ovarian
stimulation with exogenous gonadotropins allowed for
the selection of several dominant ovarian follicles,
retrieval of multiple oocytes, and improved pregnancy
rates. In the mid-1980s, published pregnancy rates docu-
mented a success rate of 20 % with one embryo, and up
to 40 % pregnancy rate per IVF attempt with the transfer
of four embryos [1]. Multiple embryos were transferred to
maximize pregnancy rates. As a result, the debate sur-
rounding the ideal number of embryos for transfer was
born and has been ongoing for the past three decades [2].
In the early 1980s, the rise in Advanced Reproductive
Technologies (ART) success rates was synonymous with
the transfer of multiple embryos and multiple gestation
pregnancy. The first report of IVF twins in 1981 was rap-
idly followed by abundant reports; multiple gestations and
IVF became forever conjoined [3, 4]. Multiple gestations
are wrought with substantial perinatal and neonatal
complications: pregnancy loss, preterm births, congenital
abnormalities, and increased perinatal mortality [5]. Like-
wise, the financial impact from the health care costs of
multiple gestations has persisted through the decades. In
the early 1990s when the incidence of multiple gestations
from IVF was 15–30 %, the delivery-related hospital
expenses was up to four times more per child for multiple
gestations compared to singletons [6]. From 1998 to 2011,
there has been a 29 % decrease in the number of multiple
gestations and 33 % decrease in higher order multiple
gestations. However, the rate of twin gestation has
plateaued and 36 % of all twins and 77 % of higher order
multiples are still due to ART [7]. As a result, annual
expenditures for iatrogenic preterm deliveries totals
twenty-six billion dollars of healthcare costs [8, 9].
Methods
A comprehensive online search of peer reviewed
published literature in Entrez Pubmed (US National
Library of Medicine, National Institute of Health;
http://www.ncbi.nlm.nih.gov/pubmed/) was conducted
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for content related to the utilization of single embryo
transfer in IVF therapy. References for this review
were identified with the use of the following terms:
infertility, in-vitro fertilization, elective single embryo
transfer, and twin gestation assisted reproductive tech-
nology. Additional references were also identified in
the bibliographies of articles identified in the primary
query. The reference lists of included articles were also
reviewed to identify additional relevant studies. Studies
were included if they met the following criteria: the study
population included women of reproductive age undergo-
ing IVF or intracytoplasmic sperm injection (ICSI) in non-
donor cycles; [2] the number of embryos transfers was
recorded for all participants; [3] the clinical outcome of
implantation and/or clinical pregnancy was recorded; and
[4] any study design except case reports.
Introduction of elective single embryo transfer
In the late 1990s, significant improvements in IVF preg-
nancy success rates challenged the mantra that the
transfer of higher numbers of embryos were required to
obtain acceptable pregnancy rates. In 1998, Templeton
et al. demonstrated that transferring four embryos re-
sulted in significant increases in multiple gestations
without improvements in pregnancy rates when com-
pared to three embryos [10]. In 1999, Gerris et al. were
the first to evaluate elective single embryo transfer
(eSET). Elective single embryo transfer (eSET) is the
intentional transfer of one embryo when there are mul-
tiple embryos of appropriate stage and quality available.
This should be differentiated from obligatory or non-
elective single embryo transfer, where the patient has
only one embryo available for transfer. This group ran-
domized women less than 34 years of age to either eSET
or double embryo transfer (DET). Although the implant-
ation rate was the same between the groups (relative risk
[RR] 0.88, 95 % CI 0.52–1.49), the ongoing pregnancy
rate was 35 % higher than the DET group. Overall, the
multiple gestation rate in the eSET group was dramatically
reduced compared to the DET and were comparable to
naturally-conceived pregnancies [11]. Subsequent studies
demonstrated similar clinical pregnancy rates between
elective single and double embryo transfer [12, 13].
In an effort to minimize the medical and financial risks
of multiple gestations, the Belgium government passed
legislation that allowed for federal reimbursement of em-
bryology laboratory expenses conditional on low number
embryo transfer. Effective July 1, 2003, women up to age
36 were only allowed a single embryo transfer. In
women between ages 36 and 39, a double embryo trans-
fer could be performed; no limitations were placed on
women older than 39 years of age. In a retrospective re-
view of the first six months after the enactment of this le-
gislation, the utilization of eSET markedly improved from
14 to 49 %, overall pregnancy rates remained stable, and
the twin pregnancy rate declined significantly [14].
Cryopreservation and elective single embryo
transfer
Development and improvements of embryo cryopreser-
vation techniques has allowed supernumerary embryos
to be retained and utilized in subsequent cycles if the
first cycle is unsuccessful [15, 16]. Thurin et al. assessed
the cumulative effect of fresh and subsequent thawed
embryo transfer on eSET success rates in a multi-
centered randomized trial. This study included 331
women less than 36 years of age, with two good-quality
embryos during their first IVF attempt. Subjects were
randomized to either single-embryo transfer followed by
single frozen-and-thawed embryo transfer (assuming no
live birth) or to double embryo transfer. They found no
statistically significant difference in live birth rate when
comparing cumulative single embryo versus double em-
bryo transfer rate (38.8 % vs. 42.9 %, P = 0.3). Compared
to the eSET arm, the rate of multiple births was signifi-
cantly greater in the double embryo group (0.8 % vs.
33.1 %, P < 0.001). Over the last decade both obser-
vational and randomized studies have consistently ob-
served similar rates of live birth rates in eSET compared
to DET, with a significant reduction in twin pregnancy
rates with eSET [17, 18].
Embryo selection
With extension of the duration of embryo culture from
2 to 3 days to 5 days (blastocyst stage) embryo(s) with
the highest implantation potential may be selected for
transfer. Improvements in implantation rates were ob-
served and single blastocyst transfers were found to have
superior pregnancy rates compared to single or double
cleavage stage (day 2 or 3) transfer [19, 20]. Single day 5
blastocyst transfer was found to have similar live birth
rates as those with two blastocysts transferred, and only
half the multiple gestation rate [21, 22]. High quality
blastocysts (defined by the 2010 Society for Assisted
Reproductive Technology (SART) grading system based
on morphology, expansion and overall quality) resulted
in significantly higher rates of live birth compared to use
of lesser quality embryos [23].
Preimplantation genetic screening’s role (PGS) in
eSET
The transfer of a single embryo requires choosing the
embryo with the best chance of implanting and progres-
sing to a live birth. Even transfer of a known euploid
embryo does not guarantee a live birth. Traditionally,
embryologists select an embryo for transfer based on
morphologic characteristics though this is not without
error. It has been shown that approximately 20 % of day
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5 embryos transferred based on this method alone may
be aneuploid [24].
The transfer of a single biopsy tested euploid embryo
may overcome the age related decline in success. The
use of PGS provides an important tool in our armament-
arium for embryo selection. This may benefit patients of
advanced reproductive age by allowing for greater suc-
cess of a single embryo transfer; particularly as multiple
gestation pregnancies may carry higher risks for these
patients. Forman et al. randomized 175 patients aged 43
and less to the transfer of 1 euploid embryo versus two
unscreened embryos and found that pregnancy rates
were no different (69 % after euploid eSET and 72 %
after untested DET, P = 0.6). Furthermore, this SET re-
sulted in fewer twin pregnancies, preterm deliveries, and
NICU admissions [25]. These pregnancy and neonatal
outcomes are now considered the standard for IVF suc-
cess and reflect the emphasis shift to provide safer and
healthier outcomes for our patients.
Candidates for eSET
Initially elective single embryo candidates were defined
as female patients less than 34–36 years old with numer-
ous ‘good quality’ embryos. The most current eSET
evidence demonstrates marked reduction in multiple
gestations and better neonatal outcomes without com-
promising live birth rates. While the benefits are clearly
present, there exists the challenge of implementing an
effective eSET protocol and choosing appropriate pa-
tients for this policy. Female age is one of the strongest
predictors of success in IVF and should be weighed in
any future eSET policies [26].
However, there exists some controversy as to which
age eSET should be offered or recommended. The
American Society of Reproductive Medicine practice
guideline from 2013 stated that good prognosis patients
less than 35 years old have a single day 5 embryo trans-
ferred (Table 1). While patients above the age of 35
reasonably may be offered transfer of 2 or 3 embryos
[27]. Since this publication, there has been considerable
work done on patients older than 35 with regards to eSET
that suggest that these guidelines may need revision. In
examining patients 38 and younger, van Montfoort et al.
compared those with good quality cleavage stage embryos
who underwent eSET versus those who received DET.
There were no significant differences in the first, second,
or third cycles in regards to ongoing pregnancy rates. Fur-
thermore, patients receiving eSET had more embryos to
freeze and thus had higher cumulative pregnancy rates
[28]. Veleva et al. followed up with a study in patients
aged 36–39 years of age. Patients with top quality embryos
who underwent eSET had similar pregnancy rates per em-
bryo and similar live birth rates when compared to DET.
Again it was demonstrated that patients who had embryos
frozen had higher cumulative pregnancy rates (54.0 %
versus 35.0 %, P < 0.0001) live births (41.8 % vs 26.7 %,
P < 0.0001) [29]. These data should be interpreted with
caution, as patients receiving eSET in both studies were
only good prognosis patients.
While there is clear data on the success of select good
prognosis patients receiving eSET below age 35, there is
relatively little data on an upper age limit. Niinimaki et
al. sought to determine if older women aged 40–44 years
old could have reasonable cumulative pregnancy rates if
an eSET policy was applied. In this retrospective study,
good prognosis patients received either an eSET or DET
in the fresh cycle. They were allowed a DET if subse-
quent frozen cycle was performed. In the fresh cycle
there were no differences in clinical pregnancy or live
birth rates between the eSET and DET groups. Interest-
ingly, cumulative clinical pregnancy and live birth was
higher in the eSET group, likely a reflection of the eSET
group having more and better quality embryos [30].
Collectively, these data suggest the upper limit of eSET
may be extended beyond the prior age guideline of
35 years. This has already been reflected in U.S. clinical
practice as rates of eSET in patients aged 35–37 has in-
creased 0.7 % per year since 2004 [31]. However, an age
based eSET policy must not discount the importance of
assessing patients who are of a good prognosis. van
Montfoort et al. conducted a randomized controlled trial
of 335 patients (<38 years old) allocated to either eSET
cycle irrespective of embryo quality or eSET only for
good embryo quality otherwise DET. Although cumu-
lative live birth rates were similar (62.4 % vs 62.6 %,
P > 0.05) they also demonstrated lower live birth rates
(21.3 % vs 13 %, P < 0.05) in the first fresh cycle in the
group randomized to eSET [32]. When reviewing SART
data, patients with the highest likelihood of a successful
IVF outcome in eSET regardless of age were patients
receiving a day 5 embryo transfer and having 3 or more
embryos to transfer, surrogate markers for improved
Table 1 Recommended limits on the numbers of embryos
to transfer
Prognosis <35 Age (yr) 35–37 38–40 41–42
Clevage- stage embryos
Favorablea 1–2 2 3 5
All others 2 3 4 5
Blastocyts
Favorablea 1 2 2 3
All others 2 2 3 3
aFavorable = first cycle of IVF, good embryo quality, excess embryos available
for cryopreservation, or previous successful IVF cycle
Reprinted from Fertil Steril, 99/1, American Society of Reproductive Medicine.
Practice Committe Opinion. Criteria for number of embryos to transfer: a
committee opinion, 44–6, Copyright (13), with permission from Elsevier [27]
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prognosis [31]. These data support eSET in good progno-
sis patients less than 38 years. There likely exists a benefit
of eSET in select patients older than 38, but the paucity of
data requires further study to determine an upper age limit.
Perinatal outcomes
Since IVF pregnancy rates continue to improve to their
highest historical levels, there has been a significant em-
phasis on infant/perinatal outcomes and ART safety.
Prior to the initiation of eSET, 30 % of IVF cycles re-
sulted in multiple gestations compared to the population
rate of 1.5 %. Severe maternal complications include
increased rates of anemia, hypertensive disorders and
pre-eclampsia, gestational diabetes, postpartum hemo-
rrhage, and operative deliveries. The European Society of
Human Reproduction and Embryology Capri Workshop
in 2000 addressed the 4 to 10-fold increase in perinatal
morbidity and mortality associated with twins. Multiple
gestations are at increased risk of preterm delivery
(particularly early preterm <32 weeks or peri-viable
delivery), fetal growth restriction and intrauterine fetal
demise of one or both twins. Long term morbidity also
includes complications from hypoxic ischemic encephal-
opathy and cognitive delays [33].
Emerging evidence has demonstrated the long-term
neonatal benefits for infants conceived with eSET. In a
meta-analysis of studies between 1999 and 2010 which
reviewed perinatal and neonatal outcomes in eSET and
DET, the risk of preterm birth and low birth weight was
minimized with eSET. However, no significant difference
were appreciated in the rates of spontaneous abortion,
early preterm birth, or perinatal mortality [34]. In a re-
view of national data submitted to the Centers for Dis-
ease Control (CDC) from 1999 to 2010, patients who
underwent single embryo transfer were twice as likely to
have a good perinatal outcome when compared to those
with more embryos transferred. The strongest predictor
for a good perinatal outcome was utilization of elective
single blastocyst transfer [31]. Analysis of the 2011 CDC
data showed women with favorable prognoses (defined
as having at least one embryo more available for cryo-
preservation) who underwent eSET, had a significant
increase in term healthy neonates and 77 % reduction in
preterm births [9]. These findings suggest that the bene-
fit of single embryo transfer extends beyond preventing
multiple pregnancies. Moreover, recent studies have
redefined the most relevant definition of IVF success as
term gestation singleton live birth [35].
Current status
Compared to their non-infertile cohorts, patients with
infertility are at least twice as likely to desire multiple
pregnancy when compared to those without trouble
conceiving [36]. It has been shown that although initially
54 % of IVF patients would prefer single embryo trans-
fer, that rate dropped dramatically to 15 % if choosing
such would reduce the chance of pregnancy by as little
as 5 % [37]. Patients planning to undergo IVF treatment
would prefer to undergo double embryo transfer result-
ing in a child with significant impairment than no child
at all [38]. Ryan et al. conducted a novel study investigat-
ing the impact of their educational campaign, in the set-
ting of an institutional mandatory single embryo transfer
policy. Following education, more patients were more
likely to choose single embryo transfer over double em-
bryo transfer (if given the theoretical option). Patients
preferred a singleton pregnancy as the desired treatment
outcome, Fig. 1 [39].
According to available data, 1.5 % of lives births in the
United States result from IVF and the mean cycle
success of rate is 46 %. In 1992, Congress enacted The
Fertility Clinic Success Rate and Certification Act that
mandated the standardized reporting of success rates by
all clinics providing ART. In the initial years that the
data were available, 58 % of transfers in women under
age 35 involved 4 or more embryos. The Society for
Assisted Reproductive Technology released their first
guidelines in 1998 outlining the maximum recom-
mended number of embryos transferred. During this
time, women who were less then 35 years old were
limited to 3 cleavage-staged embryos while women over
forty were capped at five [40]. Following serial updates
of these guidelines, there was a decline in both the num-
ber of embryos transferred and higher order multiples,
though the number of twin births remained static [41].
In the U.S., utilization has increased eight-fold since
2004, across all age groups [31]. Notably, the most sig-
nificant rise has been in the last 3 years (Fig. 2). When
compared to other developed countries, disparities per-
sist in the utilization of elective single embryo transfer
in the United States. In a review of global ART
utilization, the use of eSET in the U.S. is the lowest
among the countries reviewed. Consequently, ART twin
birth rates are 9 % higher in the U.S. compared to Eur-
ope [42]. It is hopeful, that results such as these will
serve to increase the adoption of eSET as mainstream
practice when clinically indicated in the U.S.
Financial responsibility for the individual and society
plays a major role in the decision of the number of em-
bryo(s) to transfer. Cycles financed by the couple were
less likely to utilize single embryo transfer than those
covered by insurance [43]. Initially, studies evaluating
cost effectiveness favored double over single embryo
transfer, but this was likely due to the decreased efficacy
of eSET at the time [44]. The adoption of fresh eSET
with sequential cryothaw (if indicated) has been shown
to be a cost effective approach without impacting preg-
nancy rates [45]. A recent retrospective cohort study of
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13,000 ART-related pregnancies investigated the total
expenses for the mother (including antenatal admission
and delivery) and infant(s) through the first year of life
during a 5-year period. The reduction of iatrogenic
multiple gestations to singletons was estimated to result
in a cost savings of six billion dollars annually [8].
Mandated insurance coverage for ART
Infertile couples often have been through an arduous
journey and may favor transfer of multiple embryos if
there is a small increase in pregnancy rate; regardless of
the risks. These motivations may include a desire to
become parents as quickly as possible but also may be
Fig. 1 Desired treatment outcome a before education and b after education. Reprinted from Fertil Steril, 88/2, Ryan et al. A mandatory single
blastocyst transfer policy with educational campaign in a United States IVF program reduces multiple gestation rates without sacrificing
pregnancy rates, 354–60, Copyright (2007), with permission from Elsevier [39]
Fig. 2 Cycles with single embryo transfer. Trends in the percentage of cycles using elective single embryo transfer, United States from 2005 to
2013. The data source for this figure was the Society for Assisted Reproductive Technology (SART) Clinic Outcomes Reporting System (CORS)
database (http://www.sart.org)
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financially driven. To alleviate this financial burden and
improved safety, several states have passed laws to make
IVF a covered benefit. States that have IVF insurance
coverage laws show that ART services are more frequently
utilized suggesting better access to care. In addition, these
same states have fewer embryos transferred per cycle sug-
gesting that couples are more amenable to eSET when
there is less financial strain [46]. States with mandated
coverage have fewer high-order multiple births, fewer
preterm births, and fewer low birth weight infants when
compared to states without mandated coverage [47]. One
province in Canada (Quebec) switched to public funded
IVF clinics and their results are similar to mandated insur-
ance states. Namely, there was greater ART utilization,
increased use of eSET, and fewer twin pregnancies.
Analysis showed that there was a modest increase in price
of an IVF cycle but this was offset by the downstream
savings from neonatal health care at 1 year [48]. These
data point towards better neonatal outcomes when the
financial burden of IVF is either completely or partially
alleviated. Optimistically, these data will pave the way for
expanding insurance coverage of IVF and support the
benefit of eSET.
Conclusion
The past three decades have seen the emergence of IVF as
the gold standard treatment for infertility. The era of low
live birth rates and the routine practice of multiple
embryo transfer are a thing of the past. Advancement in
embryo cryopreservation, extended embryo culture with
blastocyst selection, and preimplantation genetic screen-
ing has facilitated the expansion of elective single embryo
without compromising outcomes. Mandated infertility
coverage in Europe, Canada and selected states have re-
sulted in increased eSET utilization and decreased costs
associated with ART. Moving forward, reproductive medi-
cine should aim for the gold standard IVF outcome to be
a singleton term live birth pregnancy with eSET. When
the goal is to minimize IVF complications, multiple em-
bryo transfer does not necessarily translate to a superior
outcome. The future success of ART lies in elective single




AML and MTC drafted the manuscript. JMC and AKS supervised the
production and editing of the manuscript. All authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1Massachusetts General Hospital Fertility Center, Vincent Memorial Obstetrics
and Gynecology Service and Harvard Medical School, Boston, MA 02114,
USA. 2Department of Obstetrics, Gynecology, and Reproductive Biology,
Harvard Medical School, Boston, MA 02114, USA. 3Walter Reed Army Medical
Center, Washington, DC, USA. 4Program in Reproductive and Adult
Endocrinology, NICHD, National Institutes of Health, Bethesda, MD, USA.
5Vincent Reproductive Medicine and IVF, Vincent Department of Obstetrics
and Gynecology, Massachusetts General Hospital, Yaw 10A, 55 Fruit Street,
Boston, MA 02114, USA.
Received: 24 December 2015 Accepted: 11 May 2016
References
1. Muasher S, Wilkes C, Garcia J, Rosenwaks Z, Jones H. Benefits and risks of
multiple transfer with in vitro fertilisation. Lancet. 1984;323(8376):570.
2. Craft I, Porter R, Green S, Tucker M, Smith B, Twigg H, et al. Success of fertility,
embryo number, and in-vitro fertilisation. Lancet. 1984;323(8379):732.
3. Feichtinger W, Szalay S, Kemeter P, Beck A, Janisch H. Twin pregnancy after
laparoscopic oocyte recovery, in-vitro fertilization and embryotransfer
(author's transl). Geburtshilfe Frauenheilkd. 1982;42(3):197.
4. Kerin J, Quinn P, Kirby C, Seamark R, Warnes G, Jeffrey R, et al. Incidence of
multiple pregnancy after in-vitro fertilisation and embryo transfer. Lancet.
1983;322(8349):537–40.
5. Tummers P, De Sutter P, Dhont M. Risk of spontaneous abortion in singleton
and twin pregnancies after IVF/ICSI. Hum Reprod. 2003;18(8):1720–3.
6. Callahan TL, Hall JE, Ettner SL, Christiansen CL, Greene MF, Crowley Jr WF.
The economic impact of multiple-gestation pregnancies and the
contribution of assisted-reproduction techniques to their incidence.
N Engl J Med. 1994;331(4):244–9.
7. Kulkarni AD, Jamieson DJ, Jones Jr HW, Kissin DM, Gallo MF, Macaluso M,
et al. Fertility treatments and multiple births in the United States. N Engl J
Med. 2013;369(23):2218–25. doi:10.1056/NEJMoa1301467.
8. Allen BD, Adashi EY, Jones HW. On the cost and prevention of iatrogenic
multiple pregnancies. Reprod Biomed Online. 2014;29(3):281–5.
9. Kissin DM, Kulkarni AD, Kushnir VA, Jamieson DJ, National ARTSSG.
Number of embryos transferred after in vitro fertilization and good
perinatal outcome. Obstet Gynecol. 2014;123(2 Pt 1):239–47.
doi:10.1097/AOG.0000000000000106.
10. Templeton A, Morris JK. Reducing the risk of multiple births by transfer of
two embryos after in vitro fertilization. N Engl J Med. 1998;339(9):573–7.
11. Gerris J, De Neubourg D, Mangelschots K, Van Royen E, Van de Meerssche
M, Valkenburg M. Prevention of twin pregnancy after in-vitro fertilization or
intracytoplasmic sperm injection based on strict embryo criteria: a
prospective randomized clinical trial. Hum Reprod. 1999;14(10):2581–7.
12. Martikainen H, Tiitinen A, Tomás C, Tapanainen J, Orava M, Tuomivaara L,
et al. One versus two embryo transfer after IVF and ICSI: a randomized
study. Hum Reprod. 2001;16(9):1900–3.
13. Dhont M, editor. Single-embryo transfer. Seminars in reproductive medicine.
2001.
14. Gordts S, Campo R, Puttemans P, Brosens I, Valkenburg M, Norre J, et al.
Belgian legislation and the effect of elective single embryo transfer on IVF
outcome. Reprod Biomed Online. 2005;10(4):436–41.
15. Kahn JA, von During V, Sunde A, Sordal T, Molne K. The efficacy and
efficiency of an in-vitro fertilization programme including embryo
cryopreservation: a cohort study. Hum Reprod. 1993;8(2):247–52.
16. Freemann L, Trounson A, Kirby C. Cryopreservation of human embryos:
progress on the clinical use of the technique in human in vitro fertilization.
J In Vitro Fert Embryo Transf. 1986;3(1):53–61.
17. McLernon DJ, Harrild K, Bergh C, Davies MJ, de Neubourg D, Dumoulin JC,
et al. Clinical effectiveness of elective single versus double embryo transfer:
meta-analysis of individual patient data from randomised trials. BMJ.
2010;341:c6945. doi:10.1136/bmj.c6945.
18. Ercan CM, Kerimoglu OS, Sakinci M, Korkmaz C, Duru NK, Ergun A.
Pregnancy outcomes in a university hospital after legal requirement for
single-embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2014;175:163–6.
doi:10.1016/j.ejogrb.2014.01.008.
19. Marek D, Langley M, Gardner DK, Confer N, Doody KM, Doody KJ.
Introduction of blastocyst culture and transfer for all patients in an in vitro
fertilization program. Fertil Steril. 1999;72(6):1035–40.
20. Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A,
Devroey P. In vitro fertilization with single blastocyst-stage versus single
cleavage-stage embryos. N Engl J Med. 2006;354(11):1139–46.
Lee et al. Contraception and Reproductive Medicine  (2016) 1:11 Page 6 of 7
21. Gardner DK, Surrey E, Minjarez D, Leitz A, Stevens J, Schoolcraft WB.
Single blastocyst transfer: a prospective randomized trial. Fertil Steril.
2004;81(3):551–5.
22. Styer AK, Wright DL, Wolkovich AM, Veiga C, Toth TL. Single-blastocyst
transfer decreases twin gestation without affecting pregnancy outcome.
Fertil Steril. 2008;89(6):1702–8. doi:10.1016/j.fertnstert.2007.05.036.
23. Heitmann RJ, Hill MJ, Richter KS, DeCherney AH, Widra EA. The simplified
SART embryo scoring system is highly correlated to implantation and live
birth in single blastocyst transfers. J Assist Reprod Genet. 2013;30(4):563–7.
doi:10.1007/s10815-013-9932-1.
24. Forman EJ, Upham KM, Cheng M, Zhao T, Hong KH, Treff NR, et al.
Comprehensive chromosome screening alters traditional morphology-based
embryo selection: a prospective study of 100 consecutive cycles of planned
fresh euploid blastocyst transfer. Fertil Steril. 2013;100(3):718–24.
doi:10.1016/j.fertnstert.2013.04.043.
25. Forman EJ, Hong KH, Franasiak JM, Scott Jr RT. Obstetrical and neonatal
outcomes from the BEST Trial: single embryo transfer with aneuploidy
screening improves outcomes after in vitro fertilization without
compromising delivery rates. Am J Obstet Gynecol. 2014;210(2):157 e1–6.
doi:10.1016/j.ajog.2013.10.016.
26. Van Loendersloot L, Van Wely M, Limpens J, Bossuyt P, Repping S,
Van Der Veen F. Predictive factors in in vitro fertilization (IVF): a systematic
review and meta-analysis. Hum Reprod Update. 2010;16(6):577–89.
27. Practice Committee of American Society for Reproductive M, Practice
Committee of Society for Assisted Reproductive T. Criteria for number of
embryos to transfer: a committee opinion. Fertil Steril. 2013;99(1):44–6.
doi:10.1016/j.fertnstert.2012.09.038.
28. van Montfoort AP, Dumoulin JC, Land JA, Coonen E, Derhaag JG, Evers JL.
Elective single embryo transfer (eSET) policy in the first three IVF/ICSI treatment
cycles. Hum Reprod. 2005;20(2):433–6. doi:10.1093/humrep/deh619.
29. Veleva Z, Vilska S, Hyden-Granskog C, Tiitinen A, Tapanainen JS, Martikainen H.
Elective single embryo transfer in women aged 36–39 years. Hum Reprod.
2006;21(8):2098–102. doi:10.1093/humrep/del137.
30. Niinimaki M, Suikkari AM, Makinen S, Soderstrom-Anttila V, Martikainen H.
Elective single-embryo transfer in women aged 40–44 years. Hum Reprod.
2013;28(2):331–5. doi:10.1093/humrep/des399.
31. Steinberg ML, Boulet S, Kissin D, Warner L, Jamieson DJ. Elective single
embryo transfer trends and predictors of a good perinatal outcome–
United States, 1999 to 2010. Fertil Steril. 2013;99(7):1937–43.
doi:10.1016/j.fertnstert.2013.01.134.
32. van Montfoort AP, Fiddelers AA, Land JA, Dirksen CD, Severens JL, Geraedts JP,
et al. eSET irrespective of the availability of a good-quality embryo in the
first cycle only is not effective in reducing overall twin pregnancy rates.
Hum Reprod. 2007;22(6):1669–74. doi:10.1093/humrep/dem059.
33. Group ECW. Multiple gestation pregnancy. Hum Reprod. 2000;15(8):1856–64.
34. Grady R, Alavi N, Vale R, Khandwala M, McDonald SD. Elective single
embryo transfer and perinatal outcomes: a systematic review and meta-
analysis. Fertil Steril. 2012;97(2):324–31. doi:10.1016/j.fertnstert.2011.11.033.
35. Min JK, Breheny SA, MacLachlan V, Healy DL. What is the most relevant
standard of success in assisted reproduction? The singleton, term gestation,
live birth rate per cycle initiated: the BESST endpoint for assisted
reproduction. Hum Reprod. 2004;19(1):3–7.
36. Leiblum S, Kemmann E, Taska L. Attitudes toward multiple births and
pregnancy concerns in infertile and non-infertile women. J Psychosom
Obstet Gynecol. 1990;11(3):197–210.
37. Twisk M, van der Veen F, Repping S, Heineman M-J, Korevaar JC, Bossuyt PM.
Preferences of subfertile women regarding elective single embryo transfer:
additional in vitro fertilization cycles are acceptable, lower pregnancy rates are
not. Fertil Steril. 2007;88(4):1006–9.
38. Scotland G, McNamee P, Peddie V, Bhattacharya S. Safety versus success in
elective single embryo transfer: women’s preferences for outcomes of in
vitro fertilisation. BJOG. 2007;114(8):977–83.
39. Ryan GL, Sparks AE, Sipe CS, Syrop CH, Dokras A, Van Voorhis BJ. A mandatory
single blastocyst transfer policy with educational campaign in a United States
IVF program reduces multiple gestation rates without sacrificing pregnancy
rates. Fertil Steril. 2007;88(2):354–60. doi:10.1016/j.fertnstert.2007.03.001.
40. Medicine ASfR. Practice Committee Opinion. Guidelines on number of
embryos transferred. Birmingham: American Society for Assisted
Reproductive Medicine; 1998. doi:10.1016/j.fertnstert.2008.08.053.
41. Stern JE, Cedars MI, Jain T, Klein NA, Beaird CM, Grainger DA, et al. Assisted
reproductive technology practice patterns and the impact of embryo
transfer guidelines in the United States. Fertil Steril. 2007;88(2):275–82.
42. Maheshwari A, Griffiths S, Bhattacharya S. Global variations in the uptake
of single embryo transfer. Hum Reprod Update. 2011;17(1):107–20.
doi:10.1093/humupd/dmq028.
43. Stillman RJ, Richter KS, Banks NK, Graham JR. Elective single embryo transfer:
a 6-year progressive implementation of 784 single blastocyst transfers
and the influence of payment method on patient choice. Fertil Steril.
2009;92(6):1895–906.
44. Fiddelers AA, van Montfoort AP, Dirksen CD, Dumoulin JC, Land JA,
Dunselman GA, et al. Single versus double embryo transfer: cost-effectiveness
analysis alongside a randomized clinical trial. Hum Reprod. 2006;21(8):2090–7.
doi:10.1093/humrep/del112.
45. Veleva Z, Karinen P, Tomás C, Tapanainen JS, Martikainen H. Elective single
embryo transfer with cryopreservation improves the outcome and
diminishes the costs of IVF/ICSI. Hum Reprod. 2009;24(7):1632–9.
46. Jain T, Harlow BL, Hornstein MD. Insurance coverage and outcomes of in
vitro fertilization. N Engl J Med. 2002;347(9):661–6.
47. Boulet SL, Crawford S, Zhang Y, Sunderam S, Cohen B, Bernson D, et al.
Embryo transfer practices and perinatal outcomes by insurance mandate
status. Fertil Steril. 2015;104(2):403–9. e1.
48. Velez MP, Connolly MP, Kadoch IJ, Phillips S, Bissonnette F. Universal coverage
of IVF pays off. Hum Reprod. 2014;29(6):1313–9. doi:10.1093/humrep/deu067.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lee et al. Contraception and Reproductive Medicine  (2016) 1:11 Page 7 of 7
